These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 34019285)
1. Biophysical and Structural Methods to Study the bHLHZip Region of Human c-MYC. Zinzalla G Methods Mol Biol; 2021; 2318():21-43. PubMed ID: 34019285 [TBL] [Abstract][Full Text] [Related]
2. Crystal Structures and Nuclear Magnetic Resonance Studies of the Apo Form of the c-MYC:MAX bHLHZip Complex Reveal a Helical Basic Region in the Absence of DNA. Sammak S; Hamdani N; Gorrec F; Allen MD; Freund SMV; Bycroft M; Zinzalla G Biochemistry; 2019 Jul; 58(29):3144-3154. PubMed ID: 31260268 [TBL] [Abstract][Full Text] [Related]
3. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc. Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350 [TBL] [Abstract][Full Text] [Related]
4. Reconstitution of an E box-binding Myc:Max complex with recombinant full-length proteins expressed in Escherichia coli. Farina A; Faiola F; Martinez E Protein Expr Purif; 2004 Apr; 34(2):215-22. PubMed ID: 15003254 [TBL] [Abstract][Full Text] [Related]
5. Methods of Expression, Purification, and Preparation of the c-Myc b-HLH-LZ for Its Biophysical Characterization. Delattre P; Montagne M; Lavigne P Methods Mol Biol; 2021; 2318():13-19. PubMed ID: 34019284 [TBL] [Abstract][Full Text] [Related]
6. Design and properties of a Myc derivative that efficiently homodimerizes. Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157 [TBL] [Abstract][Full Text] [Related]
7. New structural determinants for c-Myc specific heterodimerization with Max and development of a novel homodimeric c-Myc b-HLH-LZ. Beaulieu ME; McDuff FO; Frappier V; Montagne M; Naud JF; Lavigne P J Mol Recognit; 2012 Jul; 25(7):414-26. PubMed ID: 22733550 [TBL] [Abstract][Full Text] [Related]
8. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024 [TBL] [Abstract][Full Text] [Related]
9. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper. Lavigne P; Crump MP; Gagné SM; Hodges RS; Kay CM; Sykes BD J Mol Biol; 1998 Aug; 281(1):165-81. PubMed ID: 9680483 [TBL] [Abstract][Full Text] [Related]
10. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Lüscher B; Larsson LG Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692 [TBL] [Abstract][Full Text] [Related]
11. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. Meroni G; Reymond A; Alcalay M; Borsani G; Tanigami A; Tonlorenzi R; Lo Nigro C; Messali S; Zollo M; Ledbetter DH; Brent R; Ballabio A; Carrozzo R EMBO J; 1997 May; 16(10):2892-906. PubMed ID: 9184233 [TBL] [Abstract][Full Text] [Related]
12. Preferential heterodimeric parallel coiled-coil formation by synthetic Max and c-Myc leucine zippers: a description of putative electrostatic interactions responsible for the specificity of heterodimerization. Lavigne P; Kondejewski LH; Houston ME; Sönnichsen FD; Lix B; Skyes BD; Hodges RS; Kay CM J Mol Biol; 1995 Dec; 254(3):505-20. PubMed ID: 7490766 [TBL] [Abstract][Full Text] [Related]
13. Functional interplay between c-Myc and Max in B lymphocyte differentiation. Pérez-Olivares M; Trento A; Rodriguez-Acebes S; González-Acosta D; Fernández-Antorán D; Román-García S; Martinez D; López-Briones T; Torroja C; Carrasco YR; Méndez J; Moreno de Alborán I EMBO Rep; 2018 Oct; 19(10):. PubMed ID: 30126925 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions. Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223 [TBL] [Abstract][Full Text] [Related]
15. Strep-tag II for one-step affinity purification of active bHLHzip domain of human c-Myc. Zwicker N; Adelhelm K; Thiericke R; Grabley S; Hänel F Biotechniques; 1999 Aug; 27(2):368-75. PubMed ID: 10457846 [TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by the c-Myc helix-loop-helix/leucine zipper domain in mouse 3T3-L1 fibroblasts. Kohlhuber F; Hermeking H; Graessmann A; Eick D J Biol Chem; 1995 Dec; 270(48):28797-805. PubMed ID: 7499403 [TBL] [Abstract][Full Text] [Related]
17. The leucine zippers of the HLH-LZ proteins Max and c-Myc preferentially form heterodimers. Muhle-Goll C; Nilges M; Pastore A Biochemistry; 1995 Oct; 34(41):13554-64. PubMed ID: 7577944 [TBL] [Abstract][Full Text] [Related]
18. The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes. Hurlin PJ; Ayer DE; Grandori C; Eisenman RN Cold Spring Harb Symp Quant Biol; 1994; 59():109-16. PubMed ID: 7587059 [TBL] [Abstract][Full Text] [Related]
19. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Desbarats L; Gaubatz S; Eilers M Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028 [TBL] [Abstract][Full Text] [Related]
20. Design of dominant negatives to bHLHZip proteins that inhibit DNA binding. Krylov D; Echlin DR; Taparowsky EJ; Vinson C Curr Top Microbiol Immunol; 1997; 224():169-77. PubMed ID: 9308240 [No Abstract] [Full Text] [Related] [Next] [New Search]